Author | Howard "Skip" Burris, III, MD | OncLive

Author | Howard "Skip" Burris, III, MD

Articles

Dr. Burris on Molecular Profiling in Breast Cancer

February 12, 2019

Howard "Skip" A. Burris, III, MD, chief medical officer, Sarah Cannon Research Institute, 2019 ASCO president-elect, and a 2014 Giant of Cancer Care® in Drug Development, discusses the impact of molecular profiling in breast cancer.

Dr. Burris Discusses Promise of T-DM1 in HER2+ Breast Cancer

February 05, 2019

Howard “Skip” A. Burris, III, MD, chief medical officer, Sarah Cannon Research Institute, and a 2014 Giant of Cancer Care® in Drug Development, discusses the promise of T-DM1 in the treatment of patients with HER2-positive breast cancer.

x